Literature DB >> 4377753

Giant axonal neuropathy -- a third case.

R A Ouvrier, J Prineas, J C Walsh, R D Reye, J G McLeod.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4377753

Source DB:  PubMed          Journal:  Proc Aust Assoc Neurol        ISSN： 0084-7224


× No keyword cloud information.
  7 in total

1.  Giant axonal neuropathy: report on a case with focal fiber loss.

Authors:  M Sabatelli; E Bertini; S Servidei; E Fernandez; S Magi; P Tonali
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Giant axonal neuropathy: normal protein composition of neurofilaments.

Authors:  V Ionasescu; C Searby; P Rubenstein; A Sandra; P Cancilla; J Robillard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

3.  Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

Authors:  A L Taratuto; G Sevlever; M Saccoliti; L Caceres; M Schultz
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Giant axonal neuropathy. A neuropathological study.

Authors:  H A Kretzschmar; B O Berg; R L Davis
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Giant axonal neuropathy: possibly secondary to vitamin b12 malabsorption.

Authors:  S S Schochet; A L Chesson
Journal:  Acta Neuropathol       Date:  1977-09-26       Impact factor: 17.088

6.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

7.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.